Skip to main content

Clinical trial GO29674

A Phase Ib, Open-Label, Dose-escalation Study of the safety and Pharmacokinetics of MOXR0916 and MPDL3280A in Patients with Locally Advanced or Metastatic Solid Tumors

Organ Multiples
Trial status Trial closed for recruitment
Trial type
Interventionnal with IMP
Phase Trial phase 1
Academic trial Non
Sponsor Genentech-Roche
EudraCT Identifier 2015-000516-18
Inclusion criteria any line
Last update